What insurance plans does Robert Pride, MD accept?

Aetna, Anthem BCBS Colorado, Apostrophe Health, benefitSMART, Carrum, Cigna, Claritev Multiplan / PHCS , Colorado Access, First Health, Humana Medicare Advantage, *Kaiser (depending on market), Medicare, Medicaid, Optum Health / Optum Care CO, PHPprime, Rocky Mountain Health Plans Medicaid Prime, CHP+, Valley, Monument Tier 2 & CO Doctors Plan, SMS, Select Health Colorado Public Option (Exchange) and Medicare Advantage (MA), TRICARE/HealthNET, United Healthcare

Robert Pride, MD

Breast Surgical Oncology

Accepting new patients

Skip to section

Provider Biography

Dr. Pride is a fellowship-trained breast surgical oncologist with advanced expertise in the management of breast cancer, benign breast disease, high-risk lesions, and hereditary cancer syndromes. His clinical practice is grounded in evidence-based care, multidisciplinary collaboration, and a commitment to guiding patients through every stage of their breast health journey. He has a particular interest in de-escalated surgical approaches, especially in the axilla, and incorporates advanced oncoplastic techniques to achieve optimal oncologic and aesthetic outcomes.

A former Division I athlete at Dartmouth College, Dr. Pride brings discipline, focus, and precision to his surgical practice. He completed his general surgery residency at the prestigious Mayo Clinic in Rochester, Minnesota, followed by fellowship training in breast surgical oncology through Harvard Medical School–affiliated hospitals in Boston, Massachusetts, including Massachusetts General Hospital, Brigham and Women’s Hospital, and Dana-Farber Cancer Institute.

Dr. Pride is committed to delivering personalized, compassionate care while advancing the field of breast surgery through innovation, education, and patient-centered decision-making.

Provider Specialties

Breast-Conserving Surgery
- Lumpectomy
- Partial mastectomy
- Segmental mastectomy
- Central lumpectomy
- Oncoplastic closure
Mastectomy
- Nipple-sparing mastectomy
- Skin-sparing mastectomy
- Total mastectomy
- Bilateral "double" mastectomy
- Modified radical mastectomy
- Nerve re-sensation (nerve-sparing mastectomy)
Benign and High-Risk Breast Surgery
- Excisional biopsy
- Oncoplastic closure
- Prophylactic bilateral "double" mastectomy
Lymph Node Surgery
- Sentinel lymph node surgery
- Axillary dissection/lymphadenectomy
- Targeted axillary dissection/lymphadenectomy

Introduction Video

Care Philosophy

My approach to breast cancer is grounded in the most current evidence, integrating cutting-edge surgical techniques and state-of-the-art care to deliver the best possible outcomes. I believe that optimal care is achieved through a collaborative, team-based model, working closely with medical and radiation oncology as well as dedicated support services for each patient. Above all, I am deeply committed to clear, compassionate communication, ensuring every patient feels informed, supported, and confident in their care.

Locations

10103 Ridgegate Pkwy., Ste. 350
Lone Tree, CO 80124

303-320-7826

Fax: 303-320-7842

Request Appointment View Details

Skip to section

Education

Fellowship

Massachusetts General Hospital, Brigham and Women’s Hospital and Dana-Farber Cancer Institute, Boston, MA

Residency

Mayo Clinic School of Graduate Medical Education, Rochester, MN

Medical School

University of Central Florida College of Medicine, Orlando, FL

Memberships

American Medical Association
American College of Physicians
American College of Surgeons
American Society of Breast Surgeons
Surgical Society of Oncology

Videos

Presentations

Show Presentations
- Oral Presentations
  
  2023 Intraoperative Pathology Assessment May Lead to Overtreatment of the Axilla in Clinically Node-Negative Breast Cancer Patients Undergoing Upfront Mastectomy
  24th American Society of Breast Surgeons Annual Meeting
  Boston, MA
  Won ASBrS Outstanding Scientific Presentation Award
  
  2023 Breast cancer-related lymphedema and its relationship to major landmark trials
  in surgical oncology and radiation oncology
  Society of Surgical Oncology International Conference on Surgical Cancer Care
  Boston, MA
  
  2021 Short and long-term outcomes following surgical resection of presacral tumor: A single center series of 133 patients
  American Society of Colon and Rectal Surgeons Annual Scientific Meeting
  San Diego, CA
  
  2020 Upgrade at excisional biopsy after a core needle biopsy diagnosis of classic lobular carcinoma in situ
  Accepted at 77th Annual Meeting of the Central Surgical Association
  Presented at 26th Annual Balfour Surgery Research Symposium.
  Rochester, MN
  
  Poster Presentations
  
  2023 Positive nipple margins in nipple sparing mastectomy: Management of cancer and atypia at the margin
  Harvard Surgery Research Day Symposium
  Boston, MA
  
  2022 Intestinal Perforation Secondary to Histoplasmosis: A Mayo Clinic Experience. American Society of Colon and Rectal Surgeons Annual Scientific Meeting
  Tampa, FL
  
  2021 Upgrade at excisional biopsy after a core needle biopsy diagnosis of classic lobular carcinoma in situ
  American College of Surgeons ACS Quality and Safety Conference
  Virtual Conference

Publications

Show Publications
- Original Articles
  
  1. Shanno JN, Daly AE, Anderman KJ, Santa Cruz HS, Webster AJ, Pride RM, Specht MC, Gadd MA, Oseni TO, Verdial FC, Ozmen T, Kwait R, Colwell AS, Smith BL. Positive Nipple Margins in Nipple-Sparing Mastectomy: Management of Nipples Containing Cancer or Atypia. Ann Surg Oncol. 2024 Aug;31(8):5148-5156. doi: 10.1245/s10434-024-15362-1. Epub 2024 May 1. PMID: 38691238.
  
  2. Pride RM, Glass CC, Nakhlis F, Laws A, Weiss AC, Bellon JR, Mittendorf EA, King TA, Kantor O. Intraoperative Pathology Assessment May Lead to Overtreatment of the Axilla in Clinically Node-Negative Breast Cancer Patients Undergoing Upfront Mastectomy. Ann Surg Oncol. 2023 Jul 12. doi: 10.1245/s10434-023-13898-2. Epub ahead of print. PMID: 37436607.
  
  3. Glass CC, Pride RM, Freedman RA, Mayer EL, Ogayo ER, Chavez-MacGregor M, King TA, Mittendorf EA, Kantor O. Racial Disparities in Locoregional Recurrence in Postmenopausal Patients with Stage I-III, Hormone Receptor-Positive Breast Cancer Enrolled in the NSABP B-42 Clinical Trial. Ann Surg Oncol. 2023 Sep 5. doi: 10.1245/s10434-023-14220-w. Epub ahead of print. PMID: 37670122.
  
  4. Pride RM, Jimenez RE, Hoskin TL, Degnim AC, Hieken TJ. Upgrade at excisional biopsy after a core needle biopsy diagnosis of classic lobular carcinoma in situ. Surgery. 2020 Aug 26:S0039-6060(20)30469-4. doi: 10.1016/j.surg.2020.07.025. Epub ahead of print. PMID: 32861439.
  
  5. Marthaller KJ, Johnson SP, Pride RM, Ratzer ER, Hollis HW Jr. Percutaneous embolization of thoracic duct injury post-esophagectomy should be considered initial treatment for chylothorax before proceeding with open re-exploration. Am J Surg. 2015 Feb;209(2):235-9. doi: 10.1016/j.amjsurg.2014.05.031. Epub 2014 Aug 12. PMID: 25194762.
  
  Book Chapters
  
  1. Pride RM, Boughey, JC. Chapter 17: Sentinel Lymph Node Surgery with Resection of the Index Biopsy Proven Positive Node (Targeted Axillary Dissection). Operative Techniques in Surgery, Wolters Kluwer, Philadelphia, 2023. E-pub September 21, 2022. ISBN: 9781975176471
  
  2. Pride RM, Domozych Pride R, Caravaglio J, Kim E, Siddiqui F, Vijayvargaya R, Husain M, Greenwald J. Chapter 7: Connective Tissue Diseases. University of Central Florida College of Medicine Textbook of Dermatologic Diseases. iBooks Author E-pub. 2018